[Pharmacological and clinical profile of Etravirine (Intelence)].
Iwata
Michiko
M
Fujii
Hideji
H
Yoshida
Shinya
S
Harada
Yasushi
Y
D019380:Anti-HIV Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003864:Depression, Chemical; D024882:Drug Resistance, Viral; D004359:Drug Therapy, Combination; D054303:HIV Reverse Transcriptase / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use*; D011743:Pyrimidines; D016032:Randomized Controlled Trials as Topic; D014779:Virus Replication / Q000187:drug effects*
D019380:Anti-HIV Agents; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine; C514824:reverse transcriptase, Human immunodeficiency virus 1; D054303:HIV Reverse Transcriptase